Search

Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic However, patients undergoing targeted treatment were already being seen less often, in comparison with other SACT patients, before the start of the COVID-19 pandemic. The COVID-19 pandemic has had a profound impact on healthcare services worldwide due to the redeployment of staff and suspension of many scheduled medical and surgical activities.[1] In the context of skin malignancies, treatment regimens have been modified to decrease the need for hospital visits. [Extracted from the article]

Tumoral melanosis mimicking residual melanoma after T-VEC treatment. We present the case of a 78-year-old man who was under close follow-up for Stage IV malignant melanoma. It was suggested that stable lesions should be followed up with serial biopsies to avoid unnecessary T-VEC therapy.[6] The exact prognostic implications of tumoral melanosis are still uncertain. [Extracted from the article]